Please note our privacy policy has changed. To view the policy, please go to https://corporate.thryv.com/privacy/

Details

General Info

Dynavax Technologies Corporation was founded in August 1996. The company discovers, develops and intends to commercialize products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, using proprietary approaches that alter immune system responses in specific ways. Its clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Dynavax s pipeline includes: TOLAMBA, a ragweed allergy immunotherapeutic, which has completed a large-scale Phase 2/3 clinical trial, and is in a supportive clinical trial in ragweed allergic children; HEPLISAV, a hepatitis B vaccine that is in a pivotal Phase 3 clinical trial; a cancer therapy in a Phase 2 clinical trial; and an asthma immunotherapeutic that has shown preliminary safety and pharmacologic activity in a Phase 2a clinical trial.

Hours
Do you know the hours for this business?

Contact Info

Phones:

Main - 510-848-5100

Fax - 510-848-1327

ExtraTollFree - 877-848-5100

Address:
2100 Powell St Emeryville, CA 94608

Reviews

Be the first to review!
Write a Review
Category
Research Services
Location
The Towers Emeryville Tower 2
Suggest an Edit
Are you the business owner?Claim This Business
Data provided by one or more of the following: Thryv, Data Axle, Yext.